Individual states are filling the regulatory void created by the federal
government’s failure to provide comprehensive legislation governing human
biotechnologies. This is creating an often inconsistent policy patchwork.
In response to President Bush’s restrictions on the federal funding of human
embryonic stem cell research, several states initiated their own funded
research programs. California led the
way in 2004 with Proposition 71, which set aside $3 billion of public funds
for stem cell research over ten years.